Search Results - "Wan, Linghong"

Reduced intestinal‐to‐diffuse conversion and immunosuppressive responses underlie superiority of neoadjuvant immunochemotherapy in gastric adenocarcinoma by Wang, Lei, Wan, Linghong, Chen, Xu, Gao, Peng, Hou, Yongying, Wu, Linyu, Liu, Wenkang, Tian, Shuoran, Han, Mengyi, Peng, Shiyin, Tan, Yuting, Pan, Yuwei, Ren, Yuanfeng, Li, Jinyang, Wen, Haihui, Liu, Qin, Zhang, Mengsi, Wang, Tao, Qin, Zhong‐Yi, Xiang, Junyu, Chen, Dongfeng, Li, Xianfeng, Wang, Shu‐Nan, Chen, Chuan, Li, Mengxia, Li, Fan, Wang, Zhenning, Wang, Bin

“…Neoadjuvant immunochemotherapy (NAIC) achieves superior clinical benefits over neoadjuvant chemotherapy (NAC) in multiple types of human cancers, including…”
Get full text

Effect of low dose of berberine on the radioresistance of cervical cancer cells via a PI3K/HIF-1 pathway under nutrient-deprived conditions by Zeng, Xiaozhu, Wan, Linghong, Wang, Yu, Xue, Jinmin, Yang, Huaju, Zhu, Yuxi

“…Purpose: Radiotherapy (RT) is one of the major treatments of cervical cancer. Although the prognosis of clinical cervical cancer becomes better in recent…”
Get full text

Intestinal subtype as a biomarker of response to neoadjuvant immunochemotherapy in locally advanced gastric adenocarcinoma: insights from a prospective phase II trial by Wang, Lei, Sun, Mengting, Li, Jinyang, Wan, Linghong, Tan, Yuting, Tian, Shuoran, Hou, Yongying, Wu, Linyu, Peng, Ziyi, Hu, Xiao, Zhang, Qihua, Huang, Zening, Han, Mengyi, Peng, Shiyin, Pan, Yuwei, Ren, Yuanfeng, Zhang, Mengsi, Chen, Dongfeng, Liu, Qin, Li, Xianfeng, Qin, Zhong-yi, Xiang, Junyv, Li, Mengxia, Zhu, Jianwu, Chen, Qiyue, Luo, Huiyan, Wang, Shunan, Wang, Tao, Li, Fan, Bian, Xiu-wu, Wang, Bin

“…Purpose:Neoadjuvant immunochemotherapy (NAIC) markedly induces pathologic regression in locally advanced gastric adenocarcinoma (GAC). However, specific…”
Get full text

Tumor mutation burden predicts response and survival to immune checkpoint inhibitors: a meta-analysis by Wan, Linghong, Wang, Zhi, Xue, Jinmin, Yang, Huaju, Zhu, Yuxi

“…Cancer is one of the world's top three causes of death now. Immune checkpoint inhibitors (ICIs) show encouraging ability to treat some malignancies due to its…”
Get full text

Clinical efficacy of neoadjuvant immunochemotherapy versus neoadjuvant chemotherapy for local advanced gastric adenocarcinoma by WANG Lei, WANG Lei, WAN Linghong, WANG Tao

“…Objective To evaluate the therapeutic efficacies of neoadjuvant immunochemotherapy (NAIC) and neoadjuvant chemotherapy (NAC) for local advanced gastric…”
Get full text